186 related articles for article (PubMed ID: 12395999)
1. Recent progress in the understanding of the structure-function relationships of the globular head regions of C1q.
Kishore U; Kojouharova MS; Reid KB
Immunobiology; 2002 Sep; 205(4-5):355-64. PubMed ID: 12395999
[TBL] [Abstract][Full Text] [Related]
2. Modular organization of proteins containing C1q-like globular domain.
Kishore U; Reid KB
Immunopharmacology; 1999 May; 42(1-3):15-21. PubMed ID: 10408361
[TBL] [Abstract][Full Text] [Related]
3. A recombinant homotrimer, composed of the alpha helical neck region of human surfactant protein D and C1q B chain globular domain, is an inhibitor of the classical complement pathway.
Kishore U; Strong P; Perdikoulis MV; Reid KB
J Immunol; 2001 Jan; 166(1):559-65. PubMed ID: 11123337
[TBL] [Abstract][Full Text] [Related]
4. Modular organization of the carboxyl-terminal, globular head region of human C1q A, B, and C chains.
Kishore U; Gupta SK; Perdikoulis MV; Kojouharova MS; Urban BC; Reid KB
J Immunol; 2003 Jul; 171(2):812-20. PubMed ID: 12847249
[TBL] [Abstract][Full Text] [Related]
5. Role of Ca2+ in the electrostatic stability and the functional activity of the globular domain of human C1q.
Roumenina LT; Kantardjiev AA; Atanasov BP; Waters P; Gadjeva M; Reid KB; Mantovani A; Kishore U; Kojouharova MS
Biochemistry; 2005 Nov; 44(43):14097-109. PubMed ID: 16245926
[TBL] [Abstract][Full Text] [Related]
6. Functional characterization of a recombinant form of the C-terminal, globular head region of the B-chain of human serum complement protein, C1q.
Kishore U; Leigh LE; Eggleton P; Strong P; Perdikoulis MV; Willis AC; Reid KB
Biochem J; 1998 Jul; 333 ( Pt 1)(Pt 1):27-32. PubMed ID: 9639558
[TBL] [Abstract][Full Text] [Related]
7. C1q and tumor necrosis factor superfamily: modularity and versatility.
Kishore U; Gaboriaud C; Waters P; Shrive AK; Greenhough TJ; Reid KB; Sim RB; Arlaud GJ
Trends Immunol; 2004 Oct; 25(10):551-61. PubMed ID: 15364058
[TBL] [Abstract][Full Text] [Related]
8. Existence of different but overlapping IgG- and IgM-binding sites on the globular domain of human C1q.
Zlatarova AS; Rouseva M; Roumenina LT; Gadjeva M; Kolev M; Dobrev I; Olova N; Ghai R; Jensenius JC; Reid KB; Kishore U; Kojouharova MS
Biochemistry; 2006 Aug; 45(33):9979-88. PubMed ID: 16906756
[TBL] [Abstract][Full Text] [Related]
9. Biochemical and functional characterization of the interaction between pentraxin 3 and C1q.
Nauta AJ; Bottazzi B; Mantovani A; Salvatori G; Kishore U; Schwaeble WJ; Gingras AR; Tzima S; Vivanco F; Egido J; Tijsma O; Hack EC; Daha MR; Roos A
Eur J Immunol; 2003 Feb; 33(2):465-73. PubMed ID: 12645945
[TBL] [Abstract][Full Text] [Related]
10. Complement and non-complement activating functions of C1q: a prototypical innate immune molecule.
Nayak A; Pednekar L; Reid KB; Kishore U
Innate Immun; 2012 Apr; 18(2):350-63. PubMed ID: 21450789
[TBL] [Abstract][Full Text] [Related]
11. C1q and its growing family.
Ghai R; Waters P; Roumenina LT; Gadjeva M; Kojouharova MS; Reid KB; Sim RB; Kishore U
Immunobiology; 2007; 212(4-5):253-66. PubMed ID: 17544811
[TBL] [Abstract][Full Text] [Related]
12. Specific inhibition of the classical complement pathway with an engineered single-chain Fv to C1q globular heads decreases complement activation by apoptotic cells.
Duvall MR; Hwang HY; Boackle RJ
Immunobiology; 2010 May; 215(5):395-405. PubMed ID: 19586684
[TBL] [Abstract][Full Text] [Related]
13. Localization of ligand-binding sites on human C1q globular head region using recombinant globular head fragments and single-chain antibodies.
Kojouharova MS; Tsacheva IG; Tchorbadjieva MI; Reid KB; Kishore U
Biochim Biophys Acta; 2003 Nov; 1652(1):64-74. PubMed ID: 14580997
[TBL] [Abstract][Full Text] [Related]
14. Classical complement pathway component C1q: purification of human C1q, isolation of C1q collagen-like and globular head fragments and production of recombinant C1q-derivatives. Functional characterization.
Kojouharova M
Methods Mol Biol; 2014; 1100():25-42. PubMed ID: 24218248
[TBL] [Abstract][Full Text] [Related]
15. New insights into the molecular mechanisms of classical complement activation.
Kojouharova M; Reid K; Gadjeva M
Mol Immunol; 2010 Aug; 47(13):2154-60. PubMed ID: 20542571
[TBL] [Abstract][Full Text] [Related]
16. Binding and complement activation by C-reactive protein via the collagen-like region of C1q and inhibition of these reactions by monoclonal antibodies to C-reactive protein and C1q.
Jiang HX; Siegel JN; Gewurz H
J Immunol; 1991 Apr; 146(7):2324-30. PubMed ID: 2005402
[TBL] [Abstract][Full Text] [Related]
17. Complement C1q-target proteins recognition is inhibited by electric moment effectors.
Roumenina L; Bureeva S; Kantardjiev A; Karlinsky D; Andia-Pravdivy JE; Sim R; Kaplun A; Popov M; Kishore U; Atanasov B
J Mol Recognit; 2007; 20(5):405-15. PubMed ID: 17929239
[TBL] [Abstract][Full Text] [Related]
18. Human astrovirus coat protein binds C1q and MBL and inhibits the classical and lectin pathways of complement activation.
Hair PS; Gronemus JQ; Crawford KB; Salvi VP; Cunnion KM; Thielens NM; Arlaud GJ; Rawal N; Krishna NK
Mol Immunol; 2010 Jan; 47(4):792-8. PubMed ID: 19896716
[TBL] [Abstract][Full Text] [Related]
19. Chemistry and molecular genetics of C1q.
Reid KB
Behring Inst Mitt; 1989 Jul; (84):8-19. PubMed ID: 2679537
[TBL] [Abstract][Full Text] [Related]
20. Interaction of human C1q with IgG and IgM: revisited.
Gadjeva MG; Rouseva MM; Zlatarova AS; Reid KB; Kishore U; Kojouharova MS
Biochemistry; 2008 Dec; 47(49):13093-102. PubMed ID: 19006321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
